trending Market Intelligence /marketintelligence/en/news-insights/trending/eg1hxmvgyvuf2gjzbleuwg2 content esgSubNav
In This List

Anika Therapeutics appoints independent director

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Anika Therapeutics appoints independent director

Anika Therapeutics Inc. appointed venture-backed biotech Keratin Biosciences Inc.'s president and CEO Cheryl Blanchard as an independent director.

Blanchard is also serving on the boards of SeaSpine Holdings Corp., CeramTec GmbH, Elute Inc. and Bio2 Technologies Inc.

Anika said Blanchard's appointment expanded the board to seven directors, the company said in a Sept. 5 news release, adding that it is looking to appoint an additional director in the coming months.